Mounjaro
- Home
- Services
- Mounjaro
Don’t think much, have a query? Call us now!
Hear from Our Happy Patients – Their Stories, Their Words!
EXCELLENT Based on 313 reviews Posted on Google anjana kaushalTrustindex verifies that the original source of the review is Google. I had a wonderful experience at The Face Clinic. Dr. Reema is incredibly kind, polite, and professional. She listens to all your concerns very patiently and carefully, making you feel comfortable and well cared for throughout the consultation. The quality of services provided by the clinic is top-notch. The entire team ensures that patients are comfortable Overall, if I ever need any dermatology services in the future, I will definitely visit this clinic again. It has become my go-to place, and I highly recommend it to anyone looking for expert and compassionate skincare treatment.Posted on Google Ritu BhardwajTrustindex verifies that the original source of the review is Google. A very experienced doctor.

Reviewed by Dr. Reema Arora, Founder & Medical Director, The Face Clinic | Last updated: [07-07-2026] | 20+ years in facial aesthetics & medical weight management
Mounjaro injection for weight loss in Delhi, India is emerging as one of the most effective medical solutions for individuals struggling with obesity and metabolic disorders. With rising cases of type 2 diabetes, fatty liver, and hormonal imbalance, many patients are now turning to advanced treatments like Mounjaro (Tirzepatide) weight loss injection for safe, clinically proven results. As awareness grows across India, many people now search for a mounjaro doctor near me to begin treatment under proper medical supervision, including those looking for mounjaro weight loss treatment in delhi.
Mounjaro is a next-generation, doctor-prescribed treatment that works beyond traditional weight loss methods. By activating dual hormones — GIP and GLP-1 — Tirzepatide helps reduce appetite, control cravings, improve insulin sensitivity, and support sustainable fat loss without relying on willpower alone. This dual mechanism is a key reason Tirzepatide has quickly become one of the most requested weight-loss treatments among Indian patients since its 2025 launch.
If you have tried multiple diets and weight loss medicines without success, a medically supervised Tirzepatide program offers a structured, clinically proven approach to long-term weight management. Choosing a doctor-led clinic — rather than an unsupervised source — is what determines whether results are both safe and sustainable.
Clinical evidence strongly supports its effectiveness. In large Phase 3 SURMOUNT trials, Tirzepatide demonstrated average weight loss of 15–22% over 72 weeks, with over 80% of patients achieving clinically meaningful weight reduction — improving blood sugar, cholesterol, and overall metabolic health. These results explain the sharp rise in demand since the drug’s approval by India’s CDSCO, with over 81,000 units sold in the first two months after launch.
At The Face Clinic, Hauz Khas, our doctor-led Tirzepatide program is designed for safe, personalised, and sustainable results. Whether you’re based in Delhi or travelling in for treatment, we provide complete, medically supervised care from consultation through maintenance. Unlike online or unsupervised treatments, we provide complete medical care:
This ensures patients receive a scientifically guided treatment — not a shortcut or trend. Since Tirzepatide is a prescription medication, undergoing treatment only under qualified medical supervision is non-negotiable, regardless of which city you’re accessing it from.
If you’re searching for a mounjaro doctor near me, finding a qualified, doctor-led clinic is essential for safe and effective results.
Located in Hauz Khas, South Delhi, our clinic is easily accessible for patients across South Delhi and nearby areas of New Delhi. with personalised dosing, metabolic evaluation, and continuous monitoring.
Our clinic is easily accessible for patients looking for:
👉 Book a consultation to start your medically guided weight loss journey.
Tirzepatide received approval from India’s drug regulator, CDSCO, for adults with a BMI of 30 or above, or 27 and above with an associated condition such as high blood pressure, high cholesterol, or type 2 diabetes. Eli Lilly first introduced Mounjaro in India in March 2025 as 2.5 mg and 5 mg vials, followed by the KwikPen — a prefilled, ready-to-use injection device across six dose strengths (2.5 mg to 15 mg) — in August 2025.
Within the first two months of launch, over 81,000 units were sold nationally, and Mounjaro quickly became one of India’s top-selling prescription medicines by value, according to pharmaceutical market data. Demand has continued to grow through 2026, with clinics across Delhi, Mumbai, Bengaluru, and Hyderabad reporting sustained patient interest as more Indian doctors gain experience prescribing and monitoring the treatment.
Vial vs KwikPen — Which Format Is Right for You?
Vials are typically more affordable for patients on lower starting doses (2.5 mg–5 mg). KwikPens offer greater dosing precision and convenience and are often preferred by patients progressing to higher doses (7.5 mg–15 mg). At The Face Clinic, Dr. Reema Arora helps patients choose the right format based on their prescribed dose, budget, and comfort with self-injection.
Mounjaro (Tirzepatide) is a prescription medical weight loss injection in India used for obesity and metabolic weight management under doctor supervision. It activates both GIP and GLP-1 receptors, helping regulate appetite, reduce caloric intake, improve insulin sensitivity, and support sustained fat loss.
In Phase 3 SURMOUNT trials, patients receiving Tirzepatide alongside structured lifestyle support achieved average weight reductions of approximately 15–22% over 72 weeks, with more than 80% of participants achieving at least 5% body weight reduction. These outcomes exceeded those historically observed with earlier single-hormone GLP-1 weight loss injections.
Tirzepatide’s evidence base now spans several large trials — not just the original SURMOUNT-1 study most patients hear about. In our consultations, we walk patients through what this evidence actually means for someone in India:
– For patients without diabetes: SURMOUNT-1 data showing 15–22% average weight loss over 72 weeks remains the most relevant reference point.
– For patients with type 2 diabetes: Weight loss tends to be somewhat lower (around 15–16% in trial populations), which is why we set expectations differently for this group during consultation rather than quoting a single blanket number.
– For patients who plateaued on semaglutide (Ozempic/Wegovy): Head-to-head data suggests Tirzepatide’s dual-hormone mechanism can produce a meaningfully better response, and this is one of the more common reasons patients switch to Mounjaro at our clinic.
– On long-term use: Trial data on treatment withdrawal consistently shows weight regain when medication is stopped without a structured maintenance plan — which is why our program is built around a maintenance phase from day one, not treated as optional add-on.
We don’t present clinical trial numbers as a guarantee of individual results — every patient’s response depends on baseline weight, adherence, and metabolic profile, which is exactly what the initial consultation is designed to assess.
Mounjaro (Tirzepatide) is a prescription dual-hormone weight loss injection used in structured medical weight management programs in India and internationally. Tirzepatide is scientifically classified as a dual GIP and GLP-1 receptor agonist — a mechanism that distinguishes it from earlier single-hormone GLP-1 medications.
Unlike traditional weight loss approaches that rely solely on calorie restriction, Tirzepatide works by regulating key hormonal pathways involved in appetite control and metabolic function. It activates:
• GIP (Glucose-dependent Insulinotropic Polypeptide) receptors
• GLP-1 (Glucagon-like Peptide-1) receptors
Through this dual-receptor activation, Mounjaro supports weight reduction by:
• Reducing hunger signals and food cravings
• Enhancing satiety and portion control
• Slowing gastric emptying
• Improving insulin sensitivity
• Supporting better blood glucose regulation
• Promoting sustained caloric reduction over time
In large Phase 3 SURMOUNT clinical trials, this mechanism translated into average weight reductions of approximately 15–22% over 72 weeks when combined with structured lifestyle support.
Tirzepatide may be particularly relevant for appropriately selected individuals with insulin resistance, metabolic dysfunction, weight regain after repeated dieting, perimenopausal hormonal weight changes, or long-standing obesity resistant to lifestyle modification.

Mounjaro injections in Hauz Khas are a cutting-edge medical weight loss treatment featuring tirzepatide as the active ingredient. This advanced medication has shown strong clinical results in weight reduction by working on two key metabolic hormones—GLP-1 and GIP.
These hormones play an important role in regulating appetite, controlling blood sugar levels, and improving energy metabolism. As a result, Mounjaro offers more than just weight loss in Delhi—it supports overall metabolic health improvement.
By targeting these biological pathways, Mounjaro helps reduce hunger, improve insulin response, and support sustainable fat loss. It is particularly beneficial for individuals dealing with obesity or weight-related health conditions, especially when combined with lifestyle modification and doctor supervision.
With the growing availability of tirzepatide-based treatments, patients now have access to modern medical solutions for long-term weight management. You can also explore how Ozempic weight loss in Delhi works as another GLP-1 based treatment option in comparison.

A 2025 head-to-head clinical trial (SURMOUNT-5), published in the *New England Journal of Medicine*, directly compared tirzepatide (Mounjaro) with semaglutide (Ozempic/Wegovy) in adults with obesity. Over 72 weeks, patients on tirzepatide achieved an average body weight reduction of 20.2%, compared to 13.7% with semaglutide — the first trial to compare the two medications head-to-head rather than across separate studies.
This is one of the reasons more patients ask about Mounjaro over Ozempic during consultation at The Face Clinic. That said, individual response depends on baseline weight, metabolic profile, and tolerance — which is exactly what a detailed medical evaluation is designed to assess before recommending either option.
While the US FDA has approved Mounjaro for weight management, in India it is currently used off-label under qualified medical supervision for safe, doctor-guided weight reduction and metabolic improvement.
Clinically monitored Mounjaro Weight Loss programs in India help patients achieve reduced cravings, improved insulin sensitivity, and gradual, sustainable weight reduction — all under doctor supervision at leading clinics such as The Face Clinic, Delhi.
At The Face Clinic each Mounjaro treatment plan is doctor-supervised and AI-personalized — aligned with your metabolism, hormone profile, and body goals for medically guided results.
At The Face Clinic, our approach to weight loss treatments is patient-centric and evidence-based. Here’s what makes our method unique:
In a world increasingly shaped by convenience and cutting-edge science, a provocative question is reshaping the conversation around fitness: If a weekly injection can help you lose 10–15% ofyour body weight, do you still need the gym?
Welcome to the era of GLP-1 weight loss treatments. Originally designed for managing type 2 diabetes, GLP-1 agonist weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (marketed as Mounjaro by Eli Lilly) are redefining how we think about body transformation.

Once used only for diabetes, GLP-1 therapies like Mounjaro and Ozempic are now redefining medical weight loss — offering proven, doctor-led, non-surgical results.

Mounjaro promotes holistic fat reduction by improving your overall metabolic rate — often leading to balanced body contouring and noticeable inch loss over time.
While Mounjaro is primarily used for full-body weight management, it offers benefits for:

Rapid, significant weight loss — including the 15–22% reductions seen with Tirzepatide — doesn’t only change the body. It changes the face too. Facial fat pads thin out, under-eye hollowing can become more visible, and skin laxity around the jawline and neck may increase, particularly in patients over 35 or those losing weight quickly.
Because The Face Clinic is led by a facial aesthetics specialist with 20+ years of experience — not solely a weight-loss practice — Dr. Reema Arora’s Mounjaro protocol includes a parallel assessment of facial volume and skin elasticity from the start of treatment, not as an afterthought once patients notice changes in the mirror. This allows:
– Early identification of patients likely to experience visible facial thinning
– Planning (where appropriate) for volume support or skin-tightening alongside the weight-loss timeline
– A more complete outcome — sustainable weight loss without an unintended “aged” facial appearance
This integrated face-and-body approach is a structural difference in how treatment is planned here compared to weight-loss-only clinics, where facial change is rarely addressed until after it has already occurred.
Choosing the right doctor is just as important as choosing the right medication. Successful Mounjaro (Tirzepatide) weight loss treatment requires careful patient selection, personalised dose titration, regular medical monitoring, and long-term lifestyle support to achieve safe and sustainable results.
With 20+ years of clinical experience, Dr. Reema Arora provides doctor-supervised Mounjaro weight loss treatment at The Face Clinic, Hauz Khas, South Delhi. Every treatment plan is tailored after a detailed medical assessment, taking into account your BMI, metabolic health, medical history, lifestyle, and individual weight-loss goals.
✔ 20+ years of clinical experience in doctor-led aesthetic and medical treatments.
✔ Personalised Tirzepatide treatment plans based on your individual health profile.
✔ Comprehensive medical evaluation before starting treatment.
✔ Doctor-supervised dose titration with regular follow-up and progress monitoring.
✔ Structured nutrition and lifestyle guidance to support sustainable weight loss.
✔ Evidence-based treatment protocols focused on patient safety and long-term weight management.
Whether you are looking for Mounjaro weight loss in Delhi, a Mounjaro doctor near you, or doctor-supervised Tirzepatide treatment in India, our goal is to provide personalised, medically supervised care that prioritises both safety and long-term success.
Effective Mounjaro aftercare combines nutrition support, lifestyle coaching, and metabolic monitoring — ensuring your weight-loss results remain consistent and long-term.
The journey doesn’t end after achieving weight loss goals. Maintenance and aftercare are vital to preserving results and ensuring long-term health. At The Face Clinic, we guide patients through this stage, offering:
At The Face Clinic, dosage adjustments are fully personalized — doctors assess weight trends, treatment tolerance, and metabolic response before each escalation to ensure patient safety and steady progress.
Many patients searching for Mounjaro in India want to know whether the medication is available and how they can start treatment safely. Since the availability of Mounjaro (Tirzepatide) may vary over time depending on regulatory approvals, authorised supply, and distribution, patients should always confirm the latest status with a qualified doctor rather than relying on online sellers or unofficial sources.
At The Face Clinic, South Delhi, every patient undergoes a comprehensive medical consultation before treatment is considered. If Mounjaro is clinically appropriate and available through authorised medical channels, the treatment plan is personalised according to your medical history, body mass index (BMI), metabolic health, weight-loss goals, and ongoing monitoring requirements.
Patients should avoid purchasing Mounjaro injections from unverified websites or using the medication without medical supervision. Tirzepatide is a prescription medicine, and safe treatment requires proper patient selection, gradual dose titration, regular follow-up, and monitoring for effectiveness and possible side effects.
If you are searching for “Is Mounjaro available in India?”, “How to get Mounjaro in India?”, or “Where can I get Mounjaro in Delhi?”, the safest approach is to book a consultation with a qualified doctor who can assess your suitability, explain the available treatment options, and recommend an evidence-based medical weight management plan tailored to your needs.
Mounjaro is approved by India’s drug regulator (CDSCO) for adults with a BMI of 30 or above, or 27 and above with an associated condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is a prescription-only medicine — it cannot legally be sold without a doctor’s evaluation, regardless of which city you’re in.
We regularly see patients travel to Hauz Khas from outside Delhi specifically for the combined face-and-body assessment described above, in addition to patients based locally. If you’re researching Mounjaro from elsewhere in India, the safest first step everywhere is the same: a proper medical evaluation before any prescription — not sourcing the medication independently.
The cost of Mounjaro (Tirzepatide) weight loss injection in India depends on several factors, including the prescribed dosage, treatment duration, medical supervision, and the patient’s individual weight management goals. Since Mounjaro is a prescription medication, treatment should always be personalised rather than following a one-size-fits-all approach.
At our doctor-led clinic in Delhi, every patient undergoes a detailed medical consultation before starting treatment. This allows us to determine the most appropriate dose, assess metabolic health, and create a personalised weight loss plan designed for safe and sustainable results.
| Treatment | Estimated Cost |
|---|---|
| Initial Consultation | As advised after evaluation |
| Mounjaro (Tirzepatide) Weight Loss Program | ₹20,000–₹50,000 per month |
| Follow-up Reviews & Dose Optimisation | Based on the personalised treatment plan |
The final cost may vary depending on the prescribed dose, medication availability, treatment duration, and individual medical requirements.
Rather than choosing treatment based on price alone, patients should prioritise doctor supervision, proper dose titration, regular follow-up, and long-term weight management support to maximise safety and treatment outcomes.
If you are searching for the Mounjaro injection price in India, Mounjaro cost in Delhi, or the monthly cost of Tirzepatide treatment, the most accurate estimate can only be provided after a medical assessment and personalised treatment planning.
At present, Mounjaro injections are not covered under most Indian health insurance plans, as weight-loss therapy is considered elective. However, doctor-diagnosed obesity management may qualify under select corporate or wellness policies — our team assists patients with eligibility guidance.
Beyond weight reduction, Mounjaro enhances insulin sensitivity, curbs cravings, and supports heart health — building lasting improvements in metabolic balance.
Patients who follow a consistent regimen with Mounjaro often experience enduring benefits, including:
From Hollywood icons to business leaders, these celebrities highlight how GLP-1 injections like Mounjaro, Ozempic, and Wegovy are redefining modern medical weight loss.
Hollywood and global stars have embraced this breakthrough:
Elon Musk – Admitted Ozempic helped his transformation
Whoopi Goldberg
Jim Gaffigan
Rosie O’Donnell
Sunny Hostin
Tori Spelling
Lauren Manzo
Charles Barkley
Chelsea Handler
Amy Schumer
They prove it’s more than hype—GLP-1 weight loss works.
In large Phase 3 SURMOUNT clinical trials, Tirzepatide demonstrated average body weight reductions of approximately 15–22% over 72 weeks when combined with structured lifestyle intervention. More than 80% of participants achieved at least 5% weight reduction, a threshold associated with measurable improvements in metabolic health markers.
Unlike earlier single-hormone GLP-1 weight loss injections, Tirzepatide activates both GIP and GLP-1 receptors. This dual-receptor mechanism supports appetite regulation, improved insulin sensitivity, and enhanced metabolic efficiency.
Mounjaro is administered as a once-weekly subcutaneous injection. Treatment typically begins at a lower starting dose, followed by gradual dose escalation under doctor supervision to optimise tolerance and effectiveness.
When prescribed appropriately within a medically supervised program, Mounjaro weight loss injections in Delhi are generally considered safe for carefully selected patients. Common side effects may include nausea, reduced appetite, mild gastrointestinal discomfort, or temporary digestive changes, particularly during dose escalation.
Obesity is recognised as a chronic, relapsing metabolic condition rather than a short-term issue. Discontinuation of treatment without structured lifestyle support may result in weight regain.
The cost of Mounjaro weight loss in Delhi (Tirzepatide) typically ranges from ₹25,000 to ₹50,000 per month, depending on the prescribed dosage, treatment plan, and medical supervision requirements.
If you are exploring medically supervised weight management and considering Mounjaro (Tirzepatide) weight loss injections, the first step is a comprehensive medical evaluation rather than self-prescription or unsupervised access.
At The Face Clinic, Hauz Khas, South Delhi, Dr. Reema Arora conducts structured consultations for patients seeking Mounjaro weight loss in Delhi, Each assessment includes:
• Detailed medical and metabolic history review
• BMI and body composition analysis
• Screening for contraindications and risk factors
• Personalised Tirzepatide dosing and titration planning
• Long-term metabolic health and weight maintenance strategy
Obesity is a chronic metabolic condition requiring structured management. When clinically appropriate, Mounjaro weight loss injections are incorporated into a doctor-led program designed to prioritise safety, metabolic optimisation, and sustainable long-term outcomes.
For patients exploring medically supervised Mounjaro weight loss injections in Delhi, the following related services and educational resources may provide additional context:
• Our structured doctor-led medical weight loss program:
• Comparison of Wegovy vs Mounjaro for weight management:
• Detailed guide on Ozempic (Semaglutide) weight loss:
• Transparent overview of Mounjaro price and dosage planning:
• Evidence-based discussion on GLP-1 weight loss injections:
For independent, peer-reviewed medical reading on Tirzepatide and chronic weight management:
• SURMOUNT-1 Trial (NEJM publication)
• American Association of Clinical Endocrinology (AACE) Obesity Guidelines
• National Institute for Health and Care Excellence (NICE) Pharmacological Weight Management Guidance
Speak directly with our clinic team to know the exact treatment plan, cost, and availability. Quick response on call or WhatsApp.
All treatments are subject to individual variation. Outcomes are determined following clinical evaluation by a qualified doctor.